Clinical Study of Pulp Mesenchymal Stem Cells in the Treatment of Primary Mild to Moderate Knee Osteoarthritis

Condition:   Knee Osteoarthritis Interventions:   Biological: Low Dose of Mesenchymal stem cell;   Biological: High Dose of Mesenchymal stem cell;   Drug: Sodium Hyaluronate Sponsor:   CAR-T (Shanghai) Biotechnology Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials